Title : Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression.

Pub. Date : 2021

PMID : 33747911






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression. Epirubicin integrin subunit beta 1 Homo sapiens
2 Our study demonstrates that novel lnc005620 promotes TNBC progression and chemoresistance to epirubicin via integrin beta1 both in vitro and in vivo and provides a promising therapeutic target for TNBC patients in terms of enhancing the benefits of epirubicin treatment. Epirubicin integrin subunit beta 1 Homo sapiens
3 Our study demonstrates that novel lnc005620 promotes TNBC progression and chemoresistance to epirubicin via integrin beta1 both in vitro and in vivo and provides a promising therapeutic target for TNBC patients in terms of enhancing the benefits of epirubicin treatment. Epirubicin integrin subunit beta 1 Homo sapiens